BluePrint Phase 2 Demonstrates Digital Pathology Review Equivalent to Glass Slides
17 oct. 2017 21h45 HE
|
Histogenex LLC
YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- The BluePrint Phase 2 committee today presented its findings comparing five PD-L1 IHC assays at the International Association for the Study of Lung...